Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial

JAMA

Volumn 293, Issue 4, 2005, Pages 470-476

  Willson, Douglas F ^a,b   Thomas, Neal J ^c   Markovitz, Barry P ^d   Bauman, Loren A ^e   DiCarlo, Joseph V ^f   Pon, Steven ^g   Jacobs, Brian R ^h   Jefferson, Larry S ⁱ   Conaway, Mark R ^b   Egan, Edward A ^j  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALFACTANT; PLACEBO;

ACUTE CHEST SYNDROME; ACUTE LUNG INJURY; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEAR DROWNING; NEWBORN; OXYGEN THERAPY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPSIS; TREATMENT OUTCOME;

EID: 19944431657     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.4.470     Document Type: Article

References (28)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319-323.
2. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest. 1971; 60:233-239.
3. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child. 1959;97:517-523.
4. Notter RH. Lung Surfactants. New York, NY: Marcel Dekker; 2000:207-247.
5. Bernard GR, Artigas A, Brigham KL, et al; Consensus Committee. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
6. Anzueto A, Baughman RP, Kalpalatha KG, et al. Aerolized surfactant in adult with sepsis-induced acute respiratory distress syndrome. N Engl J Med. 1996;334: 1417-1421.
7. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 155:1309-1315.
8. Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004;351:884-892.
9. Whitsett JA, Ohning BL, Ross G, et al. Hydrophobic surfactant associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used in replacement therapy. Pediatr Res. 1986;20:460-467.
10. Willson DF. Calfactant. Expert Opin Pharmacother. 2001;2:1479-1493.
11. Hall SB, Venkitataman AR, Whitsett JA, Holm BA, Notter RH. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis. 1992;145:24-30.
12. Wang Z, Notter RH. Additivity of protein and non-protein inhibitors of lung surfactant activity. Am J Respir Crit Care Med. 1998;158:28-35.
13. Willson DF, Jiao JH, Bauman LA, et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med. 1996;24:1316-1322.
14. Willson DF, Zaritsky A, Bauman LA, et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med. 1999;27:188-195.
15. Betensky RA, Schoenfeld DA. Nonparametric estimation in a cure model with random cure times. Biometrics. 2001;57:282-286.
16. Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of RDS. Pediatrics. 1997;100:31-38.
17. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 1991;88:1976-1981.
18. Gunther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996;153:176-184.
19. Veldhuizen R, McCaig L, Akino T, et al. Pulmonary surfactant subfractions in patients with the acute RDS. Am J Respir Crit Care Med. 1995;152:1867-1871.
20. Jobe AH. Pulmonary surfactant therapy. N Engl J Med. 1993;328:861-868.
21. Bersten AD, Edibam C, Hunt T et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med. 2002;105:443-448.
22. Montgomery AB, Stager MA, Carrico J, et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985;132: 485-491.
23. Ferring M, Vincent JL. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997;10:1297-1300.
24. Nogee L, Garnier G, Dietz H, et al. A mutation in the surfactant protein β gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest. 1994;93:1860-1863.
25. Clark JC, Wert SB, Bachurski C., et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A. 1995;92: 7794-7798.
26. Wang Z, Gurel O, Baatz J, et al. Differential activity and lack of synergy of lung surfactant proteins SP B and SP C in interactions with phospholipids. J Lipid Res. 1996;37:1749-1760.
27. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J. 1993;6:971-977.
28. Notter RH, Wang Z, Egan EA, Holm BA. Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids. 2002; 114:21-34.